Showing results (851-860 of 2,117) with videos related to
Sort By:
Pageof 212
International Clinical Psychopharmacology|January 1, 1993
A 24-week study of 20 mg citalopram, 40 mg citalopram, and placebo in the prevention of relapse of major depressionS A Montgomery, J G Rasmussen, P TanghøjInternational Clinical Psychopharmacology|March 14, 2002
Mianserin or placebo as adjuncts to typical antipsychotics in resistant schizophreniaR Shiloh, Z Zemishlany, D Aizenberg, et al.International Clinical Psychopharmacology|March 14, 2002
Time to study discontinuation, relapse, and compliance with atypical or conventional antipsychotics in schizophrenia and related disordersI D Glick, P H BergInternational Clinical Psychopharmacology|March 14, 2002
Olanzapine augmentation in the treatment of melancholia: the trajectory of improvement in rapid respondersG ParkerInternational Clinical Psychopharmacology|March 14, 2002
High-dose olanzapine in Huntington's diseaseR M Bonelli, G Niederwieser, G G Tribl, et al.International Clinical Psychopharmacology|January 23, 2010
The effect of OROS methylphenidate on the sleep of children with attention-deficit/hyperactivity disorderHyo-Won Kim, In-Young Yoon, Soo-Churl Cho, et al.International Clinical Psychopharmacology|January 1, 1993
A prospective evaluation of the hepatotoxicity of lofepramine in the elderlyC Kelly, S Roche, M Naguib, et al.International Clinical Psychopharmacology|May 1, 2002
Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary careA Wade, O Michael Lemming, K Bang HedegaardInternational Clinical Psychopharmacology|May 1, 2002
Treatment of generalized anxiety disorder with citalopramI Varia, F RauscherInternational Clinical Psychopharmacology|May 1, 2002
Therapeutic effects of milnacipran, a serotonin and noradrenaline reuptake inhibitor, on post-stroke depressionM Kimura, K Kanetani, R Imai, et al.Pageof 212